Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04240002 |
| Title | A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Astellas Pharma Global Development, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | USA | ITA | GBR | ESP | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | United States | Details | |
| Site DE49004 | Essen | North Rhine-Westphalia | 45147 | Germany | Details | |
| SIte IT39001 | Roma | 165 | Italy | Details | ||
| Site ES34001 | Barcelona | 08950 | Spain | Details | ||
| Site GB44001 | Birmingham | B4 6NH | United Kingdom | Details | ||
| Site GB44005 | Cardiff | CF14 4XW | United Kingdom | Details | ||
| Site UK44007 | Sutton | United Kingdom | Details |